FDA Staff Don’t Take Position on Moderna COVID-19 Booster
Food and Drug Administration staffers in an unusual move didn’t take a stance on Moderna Inc.’s MRNA +0.72% application for a booster dose, indicating there may not be sufficient data to support the extra dose.
No comments:
Post a Comment